Tanzira Zaman1, Teng Moua2, Eric Vittinghoff3, Jay H Ryu2, Harold R Collard3, Joyce S Lee4. 1. University of Colorado, Aurora, CO; Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: tanzira.zaman@cshs.org. 2. Mayo Clinic, Rochester, MN. 3. University of California San Francisco, San Francisco, CA. 4. University of Colorado, Aurora, CO.
Abstract
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a disease with a male predominance. Prior data suggest that male sex is associated with disease progression and survival. The basis for this sex difference is unknown. RESEARCH QUESTION: Are there differences in clinical disease characteristics and outcomes between men and women with IPF? STUDY DESIGN AND METHODS: Two tertiary care center IPF cohorts were pooled to analyze sex differences in outcomes of time to lung transplantation or death. Predictors of outcome that were analyzed included age, FVC % predicted, diffusion capacity for carbon monoxide (Dlco) % predicted, BMI, smoking history, and respiratory variables of cough, phlegm, and need for supplemental oxygen. The associations of these factors with mortality were estimated by sex and then compared using tests for interaction. RESULTS: There were a total of 1,263 patients in the pooled cohort with follow-up data; approximately 71% of the patients were men. Male sex was independently associated with higher risk for death or lung transplantation after adjusting for age, FVC % predicted, and Dlco % predicted (hazard ratio for men, 1.4; 95% CI, 1.2-1.7; P < .001). Older age, lower Dlco % predicted, and presence of cough or phlegm were negatively associated with transplant-free survival in men but not in women, but only the association for cough differed statistically by sex (interaction P = .007). INTERPRETATION: Male sex is associated with worse transplant-free survival in IPF. Cough may be a sex-specific predictor of survival in this population.
BACKGROUND:Idiopathic pulmonary fibrosis (IPF) is a disease with a male predominance. Prior data suggest that male sex is associated with disease progression and survival. The basis for this sex difference is unknown. RESEARCH QUESTION: Are there differences in clinical disease characteristics and outcomes between men and women with IPF? STUDY DESIGN AND METHODS: Two tertiary care center IPF cohorts were pooled to analyze sex differences in outcomes of time to lung transplantation or death. Predictors of outcome that were analyzed included age, FVC % predicted, diffusion capacity for carbon monoxide (Dlco) % predicted, BMI, smoking history, and respiratory variables of cough, phlegm, and need for supplemental oxygen. The associations of these factors with mortality were estimated by sex and then compared using tests for interaction. RESULTS: There were a total of 1,263 patients in the pooled cohort with follow-up data; approximately 71% of the patients were men. Male sex was independently associated with higher risk for death or lung transplantation after adjusting for age, FVC % predicted, and Dlco % predicted (hazard ratio for men, 1.4; 95% CI, 1.2-1.7; P < .001). Older age, lower Dlco % predicted, and presence of cough or phlegm were negatively associated with transplant-free survival in men but not in women, but only the association for cough differed statistically by sex (interaction P = .007). INTERPRETATION: Male sex is associated with worse transplant-free survival in IPF. Cough may be a sex-specific predictor of survival in this population.
Authors: M K Han; S Murray; C D Fell; K R Flaherty; G B Toews; J Myers; T V Colby; W D Travis; E A Kazerooni; B H Gross; F J Martinez Journal: Eur Respir J Date: 2008-03-05 Impact factor: 16.671
Authors: Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster Journal: Am J Respir Crit Care Med Date: 2006-06-29 Impact factor: 21.405
Authors: Ulrich Costabel; Yoshikazu Inoue; Luca Richeldi; Harold R Collard; Inga Tschoepe; Susanne Stowasser; Arata Azuma Journal: Am J Respir Crit Care Med Date: 2016-01-15 Impact factor: 21.405
Authors: Elizabeth F Redente; Kristen M Jacobsen; Joshua J Solomon; Abigail R Lara; Sarah Faubel; Rebecca C Keith; Peter M Henson; Gregory P Downey; David W H Riches Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-07-08 Impact factor: 5.464
Authors: Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson Journal: Am J Respir Crit Care Med Date: 2018-09-01 Impact factor: 21.405